Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection
et al., Reviews in Cardiovascular Medicine, doi:10.31083/j.rcm.2020.04.260, Dec 2020
HCQ for COVID-19
1st treatment shown to reduce risk in
March 2020, now with p < 0.0000000001 from 424 studies, used in 59 countries.
No treatment is 100% effective. Protocols
combine treatments.
6,600+ studies for
220+ treatments. c19early.org
|
Retrospective 922 outpatients, with 320 treated early due to age>50 or comorbidities, showing 2.2% hospitalization and 0.3% death, which authors note is considerably lower than reported in other studies in their region.
At least two of zinc, HCQ, and ivermectin were used, along with one antibiotic, and budesonide and/or dexamethasone.
Study covers ivermectin and HCQ.
Procter et al., 30 Dec 2020, peer-reviewed, 6 authors.
DOI record:
{
"DOI": "10.31083/j.rcm.2020.04.260",
"ISSN": [
"2153-8174"
],
"URL": "http://dx.doi.org/10.31083/j.rcm.2020.04.260",
"container-title": "Reviews in Cardiovascular Medicine",
"container-title-short": "Reviews in Cardiovascular Medicine",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2020,
12,
30
]
],
"date-time": "2020-12-30T09:45:31Z",
"timestamp": 1609321531000
},
"deposited": {
"date-parts": [
[
2022,
1,
31
]
],
"date-time": "2022-01-31T19:48:42Z",
"timestamp": 1643658522000
},
"indexed": {
"date-parts": [
[
2024,
5,
2
]
],
"date-time": "2024-05-02T00:06:27Z",
"timestamp": 1714608387288
},
"is-referenced-by-count": 32,
"issue": "4",
"issued": {
"date-parts": [
[
2020
]
]
},
"journal-issue": {
"issue": "4",
"published-print": {
"date-parts": [
[
2020
]
]
}
},
"language": "en",
"link": [
{
"URL": "https://rcm.imrpress.com/fileup/2153-8174/PDF/1609227832928-1230317314.pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "16242",
"original-title": [],
"page": "611",
"prefix": "10.31083",
"published": {
"date-parts": [
[
2020
]
]
},
"published-print": {
"date-parts": [
[
2020
]
]
},
"publisher": "IMR Press",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://imrpress.com/journal/RCM/21/4/10.31083/j.rcm.2020.04.260"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection",
"type": "journal-article",
"volume": "21"
}